Patients with hepatocellular carcinoma (HCC) and cirrhosis typically face limited resection options1. Advances in minimally invasive surgery2 and immunotherapy have broadened treatment strategies, including neoadjuvant approaches with tremelimumab and durvalumab, as well as 90Y transarterial radioembolization (TARE). The Arantius-first approach3 leverages anatomical landmarks to achieve precise liver resections, being particularly beneficial in complex cirrhotic patients.

The video accompanying this article is from a 78-year-old man with hepatitis B infection who was found to have a 5.8 cm HCC in segment 4a (see Video 1; a video transcript is available as Supplementary material). He was treated with entacavir, neoadjuvant tremelimumab and durvalumab4, and TARE of the left hepatic lobe. The standardized future liver remnant (sFLV)5 was estimated to be 52.9% from 30.7% after TARE, prompting surgical resection.

Video 1.

Laparoscopic left hemihepatectomy by the Arantius-first approach follow 90Y radioembolization and immunotherapy in a cirrhotic patient.

Initial mobilization included division of the falciform, left coronary ligament (Fig. 1) and upturning of the left lateral lobe, allowing for identification of Arantius’ duct between the left lateral lobe and Spiegel’s lobe without opening the lesser omentum to preserve collateral circulation. This exposure provided a clear landmark for the subsequent dissection. See Fig. 2.

Intraoperative view after dissection of the left triangular and coronary ligaments, revealing the trunks of the left hepatic vein and middle hepatic vein
Fig. 1

Intraoperative view after dissection of the left triangular and coronary ligaments, revealing the trunks of the left hepatic vein and middle hepatic vein

The left diaphragmatic vein is also identified, enhancing visualization of critical vascular structures and facilitating subsequent steps in the Arantius-first approach. LIDV (Defined as a two branch structure draining the diaphragm ending in the left renal or suprarenal vein and IVC); MHV, middle hepatic vein; LHV, left hepatic vein.

Intraoperative view highlighting the Arantius ligament, which delineates the boundary between the left lateral lobe and Spiegel’s lobe, providing a crucial anatomical landmark in the Arantius-first approach
Fig. 2

Intraoperative view highlighting the Arantius ligament, which delineates the boundary between the left lateral lobe and Spiegel’s lobe, providing a crucial anatomical landmark in the Arantius-first approach

LHV, left hepatic vein; AL, Arantius ligament.

The liver parenchyma was widely opened above Arantius’ duct, spanning from the root of the left hepatic vein (LHV) to the left Glissonean pedicle (Glt)6 (Fig. 3). The posterior aspect of the Glt was carefully exposed, creating a space behind it to allow safe insertion of a stapler from the hepatic hilum side.

Three-dimensional reconstruction illustrating the transection point from gate 3 to gate 1 of the left Glissonean pedicle, following the Sugioka approach
Fig. 3

Three-dimensional reconstruction illustrating the transection point from gate 3 to gate 1 of the left Glissonean pedicle, following the Sugioka approach

The view is positioned above the insertion of the Arantius ligament, providing a clear anatomical guide for precise transection. G3, gate 3; G1, gate 1.

From the hepatic hilum side, the medial section (segment 4) was separated from the hilar plate and the right aspect of the Glt. This technique allowed for easy encirclement of the Glt by bridging the created gap with the posterior space. Critical attention was given to avoid injury of the Glissonean pedicle or bile ducts, particularly when opening gate 36, prioritizing liver preservation over excessive pedicle manipulation. The Glt was then divided just above the bifurcation of Arantius’ duct using a linear stapler smoothly. This strategic cut minimized the risk to nearby bile ducts.

Dissection of the liver parenchyma began from the caudal-dorsal edge, following the demarcation line on the liver surface. Then, the middle hepatic vein (MHV) was approached dorsally-cephalad by elevating the left lobe, allowing for precise exposure of the vein. Using a Cavitron Ultrasonic Surgical Aspirator (CUSA), the MHV was carefully dissected from its root toward the periphery, avoiding split vein injuries in patients at higher risk due to cirrhotic tissue7. See Fig. 4.

Intraoperative view showing the tumour adhered to the middle hepatic vein
Fig. 4

Intraoperative view showing the tumour adhered to the middle hepatic vein

The middle hepatic vein was approached dorsally by elevating the left lobe, allowing for progressive exposure with a Cavitron Ultrasonic Surgical Aspirator (CUSA) from root to periphery to minimize the risk of split vein injuries. MHV, middle hepatic vein.

Branches of the MHV from the left lobe were clipped and divided at their confluence. After exposing the main MHV trunk, parenchymal dissection proceeded smoothly between the MHV and the demarcation line, a plane that theoretically lacks Glissonean branches, ensuring a clean, controlled separation of segments without jeopardizing vascular integrity and successful tumor removal (see Fig. 5).

Macroscopic pathology image of the left lobe specimen, displaying a fibrotic nodule after specimen fixation in formalin
Fig. 5

Macroscopic pathology image of the left lobe specimen, displaying a fibrotic nodule after specimen fixation in formalin

The image highlights the structural characteristics of the resected tissue, aiding in pathological assessment.

While Glissonean approaches are not widely used for laparoscopic liver resections8, the authors consider the Arantius-first approach3 for left hemihepatectomies to be an optimal technique for achieving precise and safe anatomical resections in cirrhotic patients.

Funding

This research was supported by FUJIFILM Corporation through a research loan agreement providing access to Synapses 3D reconstruction software.

Author contributions

William Kawahara (Conceptualization, Data curation, Investigation, Methodology, Software, Visualization, Writing—original draft, Writing—review & editing), Belen Rivera (Conceptualization, Investigation, Writing—review & editing), Jeffrey Roberts (Conceptualization, Data curation, Investigation, Writing—review & editing), Cathleen Huang (Data curation, Investigation, Writing—review & editing), Aishatu Ladu (Conceptualization, Investigation, Writing—review & editing), George P. Sorescu (Conceptualization, Writing—review & editing), Dmitry J. Rabkin (Conceptualization, Investigation, Writing—review & editing), Olga Kozyreva (Conceptualization, Investigation, Writing—review & editing), Fernando Rotellar (Conceptualization, Investigation, Writing—original draft, Writing—review & editing), and Eduardo A. Vega (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Supervision, Visualization, Writing—original draft, Writing—review & editing)

Disclosure

E.A.V. is a consultant for the FUJIFILM Corporation and Olympus. The authors declare no other conflict of interest.

Supplementary material

Supplementary material is available at BJS online.

Data availability

Data sharing is not applicable to this article as no new data were created or analysed.

References

1

Llovet
 
JM
,
Pinyol
 
R
,
Yarchoan
 
M
,
Singal
 
AG
,
Marron
 
TU
,
Schwartz
 
M
 et al.  
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
.
Nat Rev Clin Oncol
 
2024
;
21
:
294
311

2

Vega
 
EA
,
Kutlu
 
OC
,
Joechle
 
K
,
De La Cruz
 
N
,
Ko
 
D
,
Conrad
 
C
.
Preoperative prognosticators of safe laparoscopic hepatocellular carcinoma resection in advanced cirrhosis: a propensity score matching population-based analysis of 1799 Western patients
.
J Gastrointest Surg
 
2019
;
23
:
1157
1165

3

Ome
 
Y
,
Honda
 
G
,
Kawamoto
 
Y
.
Laparoscopic left hemihepatectomy by the Arantius-first approach: a video case report
.
J Gastrointest Surg
 
2020
;
24
:
2180
2182

4

Abou-Alfa
 
GK
,
Lau
 
G
,
Kudo
 
M
,
Chan
 
SL
,
Kelley
 
RK
,
Furuse
 
J
 et al.  
Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
.
NEJM Evid
 
2022
;
1
:
EVIDoa2100070

5

Vauthey
 
J-N
,
Chaoui
 
A
,
Do
 
K-A
,
Bilimoria
 
MM
,
Fenstermacher
 
MJ
,
Charnsangavej
 
C
 et al.  
Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations
.
Surgery
 
2000
;
127
:
512
519

6

Sugioka
 
A
,
Kato
 
Y
,
Tanahashi
 
Y
.
Systematic extrahepatic Glissonean pedicle isolation for anatomical liver resection based on Laennec’s capsule: proposal of a novel comprehensive surgical anatomy of the liver
.
J Hepatobiliary Pancreat Sci
 
2017
;
24
:
17
23

7

Honda
 
G
,
Kurata
 
M
,
Okuda
 
Y
,
Kobayashi
 
S
,
Tadano
 
S
,
Yamaguchi
 
T
 et al.  
Totally laparoscopic hepatectomy exposing the major vessels
.
J Hepatobiliary Pancreat Sci
 
2013
;
20
:
435
440

8

Ciria
 
R
,
Berardi
 
G
,
Nishino
 
H
,
Chan
 
AC
,
Chanwat
 
R
,
Chen
 
KH
 et al.  
A snapshot of the 2020 conception of anatomic liver resections and their applicability on minimally invasive liver surgery. A preparatory survey for the Expert Consensus Meeting on Precision Anatomy for Minimally Invasive HBP Surgery
.
J Hepatobiliary Pancreat Sci
 
2022
;
29
:
41
50

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

Supplementary data